Avantor (AVTR) Net Equity Issued and Repurchased (2017 - 2019)

Avantor (AVTR) posted quarterly Net Equity Issued and Repurchased of $0.0 for Q4 2019, up 100.0% quarter-over-quarter from -$100000.0 in Q3 2019.

Avantor (AVTR) Net Equity Issued and Repurchased (2017 - 2019) Analysis & Trends

Avantor's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $0.0 for Q4 2019.

In Q4 2019, Net Equity Issued and Repurchased changed N/A year-over-year to $0.0; the TTM figure through Dec 2022 stood at $0.0 (changed N/A YoY), while the FY2021 annual figure was $967.0 million, changed N/A from the prior year.
Net Equity Issued and Repurchased for Q4 2019 stood at $0.0, up from -$100000.0 in the prior quarter.
The five-year high for Net Equity Issued and Repurchased was $3.0 billion in Q4 2017, with the low at -$100000.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	-
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	-
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	29.31 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	-
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	-
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	-
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	-
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	-
10	Avantor	9.76 Bn	9.45 Bn	537.00 Mn	-

Download Data